5Am Venture Management, LLC Top Holdings and 13F Report (2024) → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) About 5Am Venture Management, LLCInvestment Activity5Am Venture Management, LLC has $446.63 million in total holdings as of March 31, 2024.5Am Venture Management, LLC owns shares of 26 different stocks, but just 14 companies or ETFs make up 80% of its holdings.Approximately 15.45% of the portfolio was purchased this quarter.About 22.86% of the portfolio was sold this quarter.This quarter, 5Am Venture Management, LLC has purchased 25 new stocks and bought additional shares in 4 stocks.5Am Venture Management, LLC sold shares of 5 stocks and completely divested from 4 stocks this quarter.Largest Holdings Enliven Therapeutics $67,474,800Entrada Therapeutics $62,466,730DIANTHUS THERAPEUTICS INC $37,260,870Merus $24,713,590Celldex Therapeutics $20,870,422 Largest New Holdings this Quarter PRAXIS PRECISION MEDICINES I $20,746,800 HoldingCentessa Pharmaceuticals $14,068,500 HoldingSilence Therapeutics $10,285,920 HoldingADVERUM BIOTECHNOLOGIES INC $7,659,157 HoldingQ32 BIO INC $4,293,978 Holding Largest Purchases this Quarter PRAXIS PRECISION MEDICINES I 340,000 shares (about $20.75M)Centessa Pharmaceuticals 1,245,000 shares (about $14.07M)Silence Therapeutics 476,200 shares (about $10.29M)ADVERUM BIOTECHNOLOGIES INC 541,666 shares (about $7.66M)Tyra Biosciences 384,319 shares (about $6.30M) Largest Sales this Quarter Viking Therapeutics 347,440 shares (about $28.49M)Enliven Therapeutics 1,325,000 shares (about $23.31M)DIANTHUS THERAPEUTICS INC 230,235 shares (about $6.91M)Biohaven 80,000 shares (about $4.38M)MoonLake Immunotherapeutics 20,317 shares (about $1.02M) Sector Allocation Over TimeMap of 500 Largest Holdings of5Am Venture Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorELVNEnliven Therapeutics$67,474,800$23,306,750 ▼-25.7%3,835,97515.1%MedicalTRDAEntrada Therapeutics$62,466,7300.0%4,408,37914.0%MedicalDIANTHUS THERAPEUTICS INC$37,260,870$6,907,050 ▼-15.6%1,242,0298.3%COMMRUSMerus$24,713,590$1,229,049 ▲5.2%548,8255.5%MedicalCLDXCelldex Therapeutics$20,870,4220.0%497,2704.7%MedicalPRAXIS PRECISION MEDICINES I$20,746,800$20,746,800 ▲New Holding340,0004.6%COM NEWVKTXViking Therapeutics$19,479,920$28,490,080 ▼-59.4%237,5604.4%MedicalPHVSPharvaris$18,432,5360.0%797,6004.1%MedicalBHVNBiohaven$17,499,269$4,375,200 ▼-20.0%319,9723.9%MedicalRNAAvidity Biosciences$16,984,9640.0%665,5553.8%MedicalTYRATyra Biosciences$15,404,487$6,302,832 ▲69.2%939,2983.4%MedicalVORVor Biopharma$15,077,2840.0%6,361,7233.4%MedicalMLTXMoonLake Immunotherapeutics$14,180,582$1,020,523 ▼-6.7%282,3133.2%MedicalCNTACentessa Pharmaceuticals$14,068,500$14,068,500 ▲New Holding1,245,0003.1%MedicalVRDNViridian Therapeutics$12,897,778$2,626,500 ▲25.6%736,5952.9%MedicalSLNSilence Therapeutics$10,285,920$10,285,920 ▲New Holding476,2002.3%MedicalANABAnaptysBio$8,056,1470.0%357,7331.8%MedicalZNTLZentalis Pharmaceuticals$7,722,4000.0%490,0001.7%MedicalADVERUM BIOTECHNOLOGIES INC$7,659,157$7,659,157 ▲New Holding541,6661.7%COM NEWRLYBRallybio$6,716,8390.0%3,630,7241.5%MedicalGHRSGH Research$6,104,609$1,793,662 ▲41.6%572,6651.4%MedicalSCPHscPharmaceuticals$6,027,2480.0%1,200,6471.3%MedicalMRSNMersana Therapeutics$5,846,4000.0%1,305,0001.3%MedicalCOGTCogent Biosciences$5,311,7570.0%790,4401.2%MedicalQ32 BIO INC$4,293,978$4,293,978 ▲New Holding251,9941.0%COMCDTXCidara Therapeutics$1,043,7500.0%1,134,5110.2%MedicalIRONDisc Medicine$0$16,994,205 ▼-100.0%00.0%MedicalMRTXMirati Therapeutics$0$11,309,375 ▼-100.0%00.0%MedicalSPRBSpruce Biosciences$0$6,926,520 ▼-100.0%00.0%MedicalFIXXHomology Medicines$0$2,757,839 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
